Literature DB >> 18049869

Preparation of porous apatite granules from calcium phosphate cement.

A C Tas1.   

Abstract

A versatile method for preparing spherical, micro- and macroporous (micro: 2-10 and macro: 150-550 microm pores), carbonated apatitic calcium phosphate (Ap-CaP) granules (2-4 mm in size) was developed by using NaCl crystals as the porogen. The entire granule production was performed between 21 and 37 degrees C. A CaP cement powder, comprising alpha-Ca3(PO4)2 (61 wt.%), CaHPO4 (26%), CaCO3 (10%) and precipitated hydroxyapatite, Ca10(PO4)6(OH)2 (3%), was dry mixed with NaCl crystals varying in size from 420 microm to 1 mm. Cement powder (35 wt.%) and NaCl (65 wt.%) mixture was kneaded with an ethanol-Na2HPO4 initiator solution, and the formed dough was immediately agitated on an automatic sieve shaker for a few minutes to produce the spherical granules. Embedded NaCl crystals were then leached out of the granules by soaking them in deionized water. CaP granules were micro- and macroporous with a total porosity of 50% or more. Granules were composed of carbonated, poorly crystallized, apatitic CaP phase. These were the first spherical and porous CaP granules ever produced from a self-setting calcium phosphate cement. The granules reached their final handling strength at the ambient temperature through the cement setting reaction, without having a need for sintering.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18049869     DOI: 10.1007/s10856-007-3326-9

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  70 in total

1.  Development of porous spherical hydroxyapatite granules: application towards protein delivery.

Authors:  W Paul; C P Sharma
Journal:  J Mater Sci Mater Med       Date:  1999-07       Impact factor: 3.896

2.  Calcium phosphate bone cements for clinical applications. Part I: solution chemistry.

Authors:  E Fernández; F J Gil; M P Ginebra; F C Driessens; J A Planell; S M Best
Journal:  J Mater Sci Mater Med       Date:  1999-03       Impact factor: 3.896

Review 3.  Some considerations on biomaterials and bone.

Authors:  Davide Zaffe
Journal:  Micron       Date:  2005-09-02       Impact factor: 2.251

4.  In vitro cartilage formation on porous hydroxyapatite ceramic granules.

Authors:  H S Cheung
Journal:  In Vitro Cell Dev Biol       Date:  1985-06

5.  Granulates based on calcium phosphate with controlled morphology and porosity for medical applications: physico-chemical parameters and production technique.

Authors:  M Fabbri; G C Celotti; A Ravaglioli
Journal:  Biomaterials       Date:  1994-05       Impact factor: 12.479

6.  Biological activity of tri-calciumphosphate/hydroxyl-apatite granules mixed with impacted morsellized bone graft. A study in rabbits.

Authors:  J J C Arts; L H B Walschot; N Verdonschot; B W Schreurs; P Buma
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2007-05       Impact factor: 3.368

7.  Effect of powder characteristics on the sinterability of hydroxyapatite powders.

Authors:  I R Gibson; S Ke; S M Best; W Bonfield
Journal:  J Mater Sci Mater Med       Date:  2001-02       Impact factor: 3.896

8.  A method to fabricate porous spherical hydroxyapatite granules intended for time-controlled drug release.

Authors:  Vladimir S Komlev; Serguei M Barinov; Elena V Koplik
Journal:  Biomaterials       Date:  2002-08       Impact factor: 12.479

9.  The cement setting reaction in the CaHPO4-alpha-Ca3(PO4)2 system: an X-ray diffraction study.

Authors:  E Fernández; F J Gil; S Best; M P Ginebra; F C Driessens; J A Planell
Journal:  J Biomed Mater Res       Date:  1998-12-05

10.  Histological evaluation of the bone response to calcium phosphate cement implanted in cortical bone.

Authors:  E M Ooms; J G C Wolke; M T van de Heuvel; B Jeschke; J A Jansen
Journal:  Biomaterials       Date:  2003-03       Impact factor: 12.479

View more
  9 in total

1.  Direct scaffolding of biomimetic hydroxyapatite-gelatin nanocomposites using aminosilane cross-linker for bone regeneration.

Authors:  Chi-Kai Chiu; Joao Ferreira; Tzy-Jiun M Luo; Haixia Geng; Feng-Chang Lin; Ching-Chang Ko
Journal:  J Mater Sci Mater Med       Date:  2012-06-05       Impact factor: 3.896

2.  Self-setting calcium orthophosphate formulations.

Authors:  Sergey V Dorozhkin
Journal:  J Funct Biomater       Date:  2013-11-12

Review 3.  Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis.

Authors:  Vuk Uskokovic
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2015       Impact factor: 4.889

Review 4.  Calcium Orthophosphate-Based Bioceramics.

Authors:  Sergey V Dorozhkin
Journal:  Materials (Basel)       Date:  2013-09-06       Impact factor: 3.623

5.  The progress of early phase bone healing using porous granules produced from calcium phosphate cement.

Authors:  P Jungbluth; M Hakimi; J P Grassmann; J Schneppendahl; A Kessner; M Sager; A R Hakimi; J Becker; J Windolf; M Wild
Journal:  Eur J Med Res       Date:  2010-05-18       Impact factor: 2.175

6.  The composite of bone marrow concentrate and PRP as an alternative to autologous bone grafting.

Authors:  Mohssen Hakimi; Jan-Peter Grassmann; Marcel Betsch; Johannes Schneppendahl; Sebastian Gehrmann; Ahmad-Reza Hakimi; Patric Kröpil; Martin Sager; Monika Herten; Michael Wild; Joachim Windolf; Pascal Jungbluth
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

7.  Calcium orthophosphates as bioceramics: state of the art.

Authors:  Sergey V Dorozhkin
Journal:  J Funct Biomater       Date:  2010-11-30

Review 8.  Synthesis of spherical calcium phosphate particles for dental and orthopedic applications.

Authors:  Marc Bohner; Solène Tadier; Noémie van Garderen; Alex de Gasparo; Nicola Döbelin; Gamal Baroud
Journal:  Biomatter       Date:  2013-04-01

9.  Human iPSC-derived iMSCs improve bone regeneration in mini-pigs.

Authors:  Pascal Jungbluth; Lucas-Sebastian Spitzhorn; Jan Grassmann; Stephan Tanner; David Latz; Md Shaifur Rahman; Martina Bohndorf; Wasco Wruck; Martin Sager; Vera Grotheer; Patric Kröpil; Mohssen Hakimi; Joachim Windolf; Johannes Schneppendahl; James Adjaye
Journal:  Bone Res       Date:  2019-10-24       Impact factor: 13.567

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.